oMeds
All comparisons
Comparison · metabolic

Compounded vs Pen Semaglutide

Compounded semaglutide is delivered from a vial via insulin-style syringe, enabling fine-titration. Branded pen semaglutide (Ozempic, Wegovy) delivers fixed-step doses. The choice is driven by titration agility, supply, and cost under provider review.

Reviewed by Dr. Laura PurdyMay 29, 2026
Attribute
Compounded semaglutide (vial)
Branded pen semaglutide
Form factor
Vial + syringe
Prefilled pen
Titration flexibility
Fine, provider-tuned
Fixed-step
Supply continuity
Available via licensed compounding
Subject to periodic shortages
Cost
Lower out-of-pocket typical
Higher; insurance-dependent
Regulatory
503A/503B oversight
FDA-approved
Pathway
Metabolic optimization (default)
Available where indicated
Choose Compounded semaglutide (vial)

Compounded vial-based semaglutide is the modern default in the oMeds metabolic pathway due to titration flexibility and supply continuity.

Choose Branded pen semaglutide

Branded pen semaglutide is appropriate where insurance coverage or patient preference aligns.

Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.

Frequently asked

Is compounded semaglutide safe?

Compounded preparations from licensed pharmacies are regulated; safety is provider-reviewed at every consult.

Does titration matter clinically?

Yes — finer titration supports tolerability and adherence under provider review.

Next step

Take the optimization assessment.

The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.

Begin assessment